Ballantyne Therapeutics Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Latest Deal Type
  • Conv. Debt
  • Latest Deal Amount
  • $565K
Latest Deal Amount

Ballantyne Therapeutics General Information

Description

The company is currently operating under stealth mode.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Other Business Products and Services
Primary Office
  • 7805 Pemswood Street
  • Charlotte, NC 28277
  • United States
+1 (704) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ballantyne Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Convertible Debt 16-Oct-2015 $565K 00000 Completed Startup
To view Ballantyne Therapeutics’s complete valuation and funding history, request access »

Ballantyne Therapeutics Executive Team (2)

Name Title Board Seat Contact Info
Michael Roberts Ph.D Chief Executive Officer & President
You’re viewing 1 of 2 executive team members. Get the full list »

Ballantyne Therapeutics Board Members (1)

Name Representing Role Since
Simon Pedder Ph.D Self Board Member 000 0000
To view Ballantyne Therapeutics’s complete board members history, request access »